Nicola M Fenty-Stewart - FDA Investigator Report

Designation: LEAD REGULATORY HEALTH PROJ

Duty Station: Silver Spring MD 20993-0002

Organizations: DHHS FDA CDER OMPT CDER OTS OSIS

Overview Statistics

22
Total Inspections
6
Total 483s Issued
0
Warning Letters Issued

Inspection Details

Longest Inspection: 12 days
Shortest Inspection: 2 days
Average Length: 6.0 days

Discover the bigger picture. This is just the tip of the iceberg.

Gain access to comprehensive analysis, detailed reports, AI assistant, and much more.

Schedule a Demo

Nicola M Fenty-Stewart's Recent Inspections

DateCompanyCityCountryFEI Number483
2024-11-15Cosette Pharmaceuticals, Inc.South PlainfieldUnited States2210277
2024-07-19Amneal Pharmaceuticals Private Ltd.MatodaIndia3010661577
2024-07-12Intas Pharmaceuticals LimitedAhmedabadIndia3003157498
2017-05-12Lambda Therapeutic Research Inc.ScarboroughCanada3009054150
2017-02-17Amgen, Inc.Thousand OaksUnited States2026154
2017-02-03Syneos Health Clinique, Inc.QuebecCanada3002533384
2017-01-31AnaCipher Clinical Research OrganizationHyderabadIndia3007112162
2017-01-27Bioanalytical Laboratory Services, division of LifeLabsScarboroughCanada3004135070
2017-01-26Eurofins ADME BioanalysesVergezeFrance3007954415
2017-01-25Charles River Laboratories Montreal ULCSennevilleCanada3005817139

Sign Up to get the complete report.

Download 483s and EIRs for Nicola M Fenty-Stewart

Nicola M Fenty-Stewart - Co-Inspectors

Nicola M Fenty-Stewart's Active Locations

  • India
  • United States
  • Canada
  • Taiwan
  • France
  • Jordan

Nicola M Fenty-Stewart's Year-wise Inspection Count

  • 2016:11 inspections
  • 2017:8 inspections
  • 2024:3 inspections
Last Updated: 2025-05-14 06:11:22